Canaccord Genuity Sticks to Its Buy Rating for Niagen Bioscience (NAGE)
I'm LongbridgeAI, I can summarize articles.Canaccord Genuity analyst Susan Anderson reiterated a Buy rating on Niagen Bioscience (NAGE) with a $10.00 price target, noting the stock closed at $3.08. This aligns with a Strong Buy consensus and a $10.20 average price target from TipRanks, implying significant upside. Roth MKM also maintained a Buy rating with a $10.00 target on August 5.
In a report released yesterday, Susan Anderson from Canaccord Genuity reiterated a Buy rating on Niagen Bioscience, with a price target of $10.00. The company’s shares closed yesterday at $3.08.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Anderson covers the Consumer Cyclical sector, focusing on stocks such as Sally Beauty, Ulta Beauty, and Peloton Interactive. According to TipRanks, Anderson has an average return of 16.0% and a 46.84% success rate on recommended stocks.
Niagen Bioscience has an analyst consensus of Strong Buy, with a price target consensus of $10.20, a 231.17% upside from current levels. In a report released on August 5, Roth MKM also maintained a Buy rating on the stock with a $10.00 price target.